Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Calcium-binding protein 3
(
CBP3
) expression was up-regulated under the control of the actin 15 promoter and down-regulated by RNA interference in Dictyostelium discoideum. The overexpression of
CBP3
accelerated cell aggregation and formed small aggregates and fruiting body.
CBP3
-inhibited cells showed uneven aggregation and increased slug trail lengths toward the directed light, whereas
CBP3
-overexpressing cells showed the opposite phenomena. Under dark condition, the enhanced slug trail length was also observed in the
CBP3
-inhibited cells. Yeast two-hybrid screening identified actin 8 as interacting protein with
CBP3
. The interaction between
CBP3
and actin was confirmed by
beta-galactosidase
assay and surface plasmon resonance.
CBP3
was associated with Triton X-100-insoluble cytoskeleton in the presence of Ca(2+) and the interaction of
CBP3
with cytoskeleton was increased by the addition of Ca(2+). Using fluorescence microscopy,
CBP3
was also shown to associate with the actin cytoskeleton during development. Subcellular fractionation indicated that
CBP3
was enriched in cytosolic fraction. Taken together, these results suggest that
CBP3
interacts with actin cytoskeleton and has a role during cell aggregation and slug migration of Dictyostelium.
...
PMID:Dictyostelium CBP3 associates with actin cytoskeleton and is related to slug migration. 1584 41